Medicago has started on November 12th, 2020 the phase 2/3 of the clinical development of its COVID-19 vaccine candidate, with the objective of completing the development program and submitting a dossier to authorities by the middle of 2021.
Is a new COVID-19 surge expected?
Another surge of COVID-19 is likely to hit the United States this winter, according to experts at the Institute for Health Metrics and Evaluation of the University of Washington, which accurately forecasted the COVID-19 waves last winter and summer.
When was the Moderna COVID-19 vaccine approved?
Moderna COVID-19 Vaccine
On December 18, 2020, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the second vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
